Sanofi-aventis announced that Schweizerhall Holding AG/Cimex AG intends to launch a generic of Plavix (Clopidogrel) into the German market.
Although sanofi-aventis does not currently have precise information related to these reports, sanofi-aventis points out that Clopidogrel, marketed in Germany as Plavix by sanofi-aventis and Iscover by Bristol-Myers Squibb, currently still benefits from EU Regulatory Data Protection.
Sanofi-aventis is currently evaluating its legal and regulatory options and will vigorously defend intellectual property rights, including patent protection, in Germany.